ALLYSSA BEALL: Open Payments
NPI 1285295865 · PARAGOULD, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,076 in 113 payments from 14 companies in 2025. Trend: 2023 $2,495 · 2024 $1,455 · 2025 $2,076
Food & beverage: $2,076
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 26 | $769 |
| PFIZER INC. | 15 | $304 |
| Novo Nordisk Inc | 18 | $232 |
| Amgen Inc. | 14 | $151 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $119 |
| Lilly USA, LLC | 6 | $86 |
| Lundbeck LLC | 4 | $78 |
| Otsuka America Pharmaceutical, Inc. | 4 | $77 |
| Phathom Pharmaceuticals, Inc. | 7 | $63 |
| ABBVIE INC. | 4 | $61 |
Products named: FARXIGA, AIRSUPRA, NURTEC ODT, REXULTI, TRINTELLIX, Wegovy, MOUNJARO, Ozempic.
Industry payments across AR — which companies pay providers there.
